Cost-effectiveness analyses for the primary outcome
Cost-effectiveness analyses of training: a manager’s guide
9
The role of cognition in cost-effectiveness analyses of behavioral interventions
9
The role of cognition in cost-effectiveness analyses of behavioral interventions
9
Experiences of structured elicitation for model based cost-effectiveness analyses
9
Experiences of structured elicitation for model based cost-effectiveness analyses
10
An Introduction to Using WinBUGS for Cost-Effectiveness Analyses in Health Economics
84
Incorporating equity into cost-effectiveness analyses of obesity prevention policies
217
Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses : second panel on cost-effectiveness in health and medicine
12
Statin cost effectiveness in primary prevention: A systematic review of the recent cost effectiveness literature in the United States
6
The Multinational Nature of Cost-Effectiveness Analyses Alongside Multinational Clinical Trials
8
Comparative and Cost-Effectiveness Analyses of Resident Quality Outcomes in Nursing Homes
151
Effectiveness and cost-effectiveness of ehealth interventions in somatic diseases: A systematic review of systematic reviews and meta-analyses
25
Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand
7
Performance and Cost-effectiveness Analyses for Cloud Services Based on Rejected and Impatient Users
12
Methods for estimating subgroup effects in cost-effectiveness analyses that use observational data.
10
UNCERTAINTY IN COST-EFFECTIVENESS ANALYSES: PROBABILISTIC UNCERTAINTY ANALYSIS AND STOCHASTIC LEAGUE TABLES
20
Modelling the cost-effectiveness of pay-for-performance in primary care in the UK
13
Influence of peer review on the reporting of primary outcome(s) and statistical analyses of randomised trials
9
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of
97
Incorporating external evidence in trial based cost effectiveness analyses: the use of resampling methods
9